Scoop has an Ethical Paywall
Work smarter with a Pro licence Learn More

Video | Agriculture | Confidence | Economy | Energy | Employment | Finance | Media | Property | RBNZ | Science | SOEs | Tax | Technology | Telecoms | Tourism | Transport | Search

 

Quayside Holdings Takes Significant Stake in HoneyLab

Quayside Holdings Takes Significant Stake in HoneyLab

Deal gives Quayside a significant stake in the rapidly-growing BoP healthcare company 22 June 2016 – Quayside Holdings, has today announced that they have taken a significant stake in the Bay of Plenty-based healthcare company HoneyLab. The investment, facilitated by Northington Partners, allows HoneyLab to rapidly grow its R&D and commercialisation programmes.

HoneyLab CEO Laurence Greig said that after considering its options in relation to capital raising, including both local and overseas investors, HoneyLab felt that Quayside Holdings were the perfect partner. “Quayside present us with an investor that adds so much more than just capital”, he said. “Their understanding and support for our strategy of developing licensable IP was instant”.

Scott Hamilton, the Chief Executive of Quayside Holdings, said that “we are excited by the potential for HoneyLab and were drawn to the company by its focus on innovation”.

HoneyLab are a Bay of Plenty-based healthcare company developing products for skin conditions, pain, nutrition and even the common cold. The company is well advanced in discussions with global consumer healthcare pharmaceutical companies on licensing its patented technology. HoneyLab products are in demand after a series of strongly positive clinical trial results which have shown them to be effective for conditions including acne, rosacea and cold sores. CEO Laurence Greig said that as well as having more than 10 products currently in market, HoneyLab had a large pipeline of products undergoing research and development and that the investment from Quayside would accelerate their development and readiness for commercial release.

Quayside CEO Scott Hamilton sees the investment as complimentary to its existing portfolio with considerable growth potential. Similar to recent direct investments, HoneyLab provides a significant value-add opportunity in the agribusiness sector as identified in the Toi Moana Bay of Plenty Growth Study.

ENDS

Advertisement - scroll to continue reading

Are you getting our free newsletter?

Subscribe to Scoop’s 'The Catch Up' our free weekly newsletter sent to your inbox every Monday with stories from across our network.

© Scoop Media

Advertisement - scroll to continue reading
 
 
 
Business Headlines | Sci-Tech Headlines

 
GenPro: General Practices Begin Issuing Clause 14 Notices

GenPro has been copied into a rising number of Clause 14 notices issued since the NZNO lodged its Primary Practice Pay Equity Claim against General Practice employers in December 2023.More

SPADA: Screen Industry Unites For Streaming Platform Regulation & Intellectual Property Protections

In an unprecedented international collaboration, representatives of screen producing organisations from around the world have released a joint statement.More

 
 
 
 
 
 
 
 
 
 
 
 

Join Our Free Newsletter

Subscribe to Scoop’s 'The Catch Up' our free weekly newsletter sent to your inbox every Monday with stories from across our network.